We serve Chemical Name:2-benzoyl-5-norbornene CAS:6056-35-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-benzoyl-5-norbornene
CAS.NO:6056-35-5
Synonyms:MFCD00167569;2-Benzoyl-5-norbornene,mixture of endo and exo;EINECS 227-983-0;5-NORBORNEN-2-YL PHENYL KETONE;Mixtureofendoandexo];2-Benzoylnorborna-5-ene;norborn-5-en-2-yl phenyl ketone;2-Phenyl-5-norbornene;5-NORBORNENE-2-BENZOYL
Molecular Formula:C14H14O
Molecular Weight:198.26000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:122-124ºC2 mm Hg(lit.)
Density:1.115 g/mL at 25ºC(lit.)
Index of Refraction:n20/D 1.568(lit.)
PSA:17.07000
Exact Mass:198.10400
LogP:3.08150
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like MFCD00167569 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-NORBORNENE-2-BENZOYL physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Benzoyl-5-norbornene,mixture of endo and exo Use and application,Mixtureofendoandexo] technical grade,usp/ep/jp grade.
Related News: Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. 6-chloro-8,11,12-trioxo-7,8,11,12-tetrahydroquinolino[4′,3′:3,4]pyrazolo[5,1-b]quinazoline-9,10-dicarbonitrile manufacturers There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% 2-(hydroxyimino)-1-(thiophen-2-yl)butane-1,3-dione suppliers During an investor event last month, Walmsley laid out her blueprint for the new GSK. It features a 5% average sales growth rate in the next five years, leading to total sales of £33 billion ($46 billion) by 2031. ETHYL-(2S,3S)-(P-NITROPHENYL)-OXIRANE-2,3-DICARBOXYLATE vendor & factory.